Q1 2026 Earnings Call April 29, 2026 10:00 AM EDTCompany ParticipantsRobert Wright - Executive Vice PresidentAvigal Soreq ...
Under new state legislation, developers of large-scale renewable energy and battery storage projects must complete a Social ...
Good day, and welcome to Ionis' First Quarter 2026 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the over to Wade Walke, Senior Vice ...
2don MSN
Earnings Season Surprises
With earnings season now in full swing, the team takes a look at the latest results from Tesla and some of the most prominent ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...
Caitlin Havener on MSN
Joint health 101: How to keep your knees and ankles happy as you age
Most of us don't think about our knees and ankles until they start complaining. One morning you get out of bed, take a step, ...
In Europe, the SC formulation of daratumumab, another anti-CD38 antibody, recently received a label update that allowed ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...
Many are surprised to learn that 45Q tax credits have been around for nearly 20 years. Over this period, the oil and gas ...
West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the first quarter of 2026.
Revenues of $2.05 billionNet income of $19 million, or $0.05 per shareAdjusted EBITDA* of $177 millionBookings of $520 million, representing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results